Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

Bullboard (TSXV:TLT)

View:
Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... Next
Comment by tdon1229on Jun 14, 2024 1:50pm

RE:Obviously

Recall that they entered into Phase II with around $10 million CDN which was to pay for the entire study and the beginning of Phase I for GBM/NSCLC.  I guess they figure they were able to make ...more  
195
Discussion
Comment by wildbird1on Jun 14, 2024 1:50pm

RE:Obviously

Wow!!!! Camphikefish, that is a beautifully written post, and 100% plausible. Thank's you.
107
Discussion
Comment by menoalittleon Jun 14, 2024 12:55pm

RE:Obviously

I agree. 'nuf said.
95
Discussion
Post by Camphikefishon Jun 14, 2024 12:50pm

Obviously

1. Someone / some entity out there must be wanting to buy a huge chunk and is showing interest (could be wrong but what else would indicate to the company they can secure $10 million in 1 week based ...more  
401
Discussion
Comment by plantraderon Jun 14, 2024 12:29pm

RE:Modulight Spotlights Theralase's Anti-viral Research

Sounds great. Hopefully the potential is actualized someday. Also wonder if they're looking to get out of the device business since they're using Modulight's equipment at least some of the ...more  
115
Discussion
Post by Eoganachton Jun 14, 2024 11:58am

Modulight Spotlights Theralase's Anti-viral Research

Dr. McFarland uses Finland based Modulight lasers in her lab.  Modulight's ML6600 laser was also used in the University of Manitoba Ruvidar anti-viral research. Modulight Spotlights: LASER ...more  
229
Discussion
Comment by plantraderon Jun 14, 2024 11:04am

RE:RE:We are # 1 on the bullboards today

We all know small pharma CEOs read bullboards. LOL 
81
Discussion
Comment by StevenBirchon Jun 14, 2024 11:00am

RE:RE:RE:RE:RE:I have to say I am upset, 10 million seems too much in 2024,

It would be nice if they raise what they can and have someone to fill the balance, at least it's only a week away.
92
Discussion
Comment by menoalittleon Jun 14, 2024 10:56am

RE:RE:We are # 1 on the bullboards today

LOL...  obviously not, Gooseybear (or they'd have already taken us out.)
71
Discussion
Comment by Gooseybearon Jun 14, 2024 10:46am

RE:We are # 1 on the bullboards today

Do big pharma CEOs read bullboards?
61
Discussion
Comment by CAinPlapon Jun 14, 2024 10:01am

RE:RE:RE:I have to say I am upset, 10 million seems too much in 2024,

Thank you for your ongoing support.   Theralase® has commenced a non brokered private placement to raise up to $CAN 10 M to close on or about Friday, June 21st, 2024. Please see below ...more  
219
Discussion
Comment by Lesalpes29on Jun 14, 2024 9:44am

RE:RE:I have to say I am upset, 10 million seems too much in 2024,

I recieved the e-mail yesterday but can't see the 10M they are willing to raise. We have to call them to know it?
84
Discussion
Comment by plantraderon Jun 14, 2024 9:27am

RE:I have to say I am upset, 10 million seems too much in 2024,

Could be, or it could be that they finally want to start progressing on some of the other indications. Maybe specifically because they see that being a one trick pony is not working out very well so ...more  
130
Discussion
Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT

Visit Facebook Visit X Visit Linked In Visit Instagram Visit Youtube



INVESTORS & MEDIA OVERVIEW FINANCIAL FILINGS PRESENTATIONS MEDIA FACT SHEETS MANAGEMENT

Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 68 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250